Kurt Azarbarzin

Mr. Azarbarzin brings a highly experienced background including nearly 40 years in advanced surgical technology companies to the board. He currently serves as CEO at ColubrisMX, the pioneering developer of endoluminal and single-port robotic platforms. Previously, Mr. Azarbarzin was the global head of digital science/robotics at Ethicon following his appointment as the president and chief executive officer of Verb Surgical Robotics, Inc., the joint venture between Google and Johnson & Johnson which was acquired by J&J in late 2019. Mr. Azarbarzin was founder and chief executive officer of venture-backed SurgiQuest, Inc., a medical device company focused on minimally invasive surgery that was acquired for $265 million by CONMED Corporation in January 2016. Prior to SurgiQuest, he spent 21 years at US Surgical Corporation/Tyco Healthcare, most recently as global vice president of research and development. Mr. Azarbarzin also serves a member of the board at TELA Bio, Inc., and is a member of the executive board at the Center for Biomedical Innovation and Technology at Yale University.